KR
50
5
WFC
58
8
MSFT
55
2
UNH
42
6
HUM
25
4
BF.B
35
2
O
26
16
CVS
27
2
ESS
44
5
NVDA
52
5
ABBV
40
5
GD
42
4
FAST
41
7
CAT
47
3
NKE
36
2
KSS
36
2
KEY
24
2
CVX
25
14
VRSK
54
2
NRG
32
5
KR
50
5
WFC
58
8
MSFT
55
2
UNH
42
6
HUM
25
4
BF.B
35
2
O
26
16
CVS
27
2
ESS
44
5
NVDA
52
5
ABBV
40
5
GD
42
4
FAST
41
7
CAT
47
3
NKE
36
2
KSS
36
2
KEY
24
2
CVX
25
14
VRSK
54
2
NRG
32
5
Financhill
Back

Cassava Sciences Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
19

SAVA
Cassava Sciences

Last Price:
$2.36
Seasonality Move:
34.39%
Sell
27

ALNY
Alnylam Pharmaceuticals

Last Price:
$245.56
Seasonality Move:
2.78%
Sell
19
Cassava Sciences (SAVA) is a Sell

Is Cassava Sciences a Buy, Sell or Hold?

  • The current Cassava Sciences [SAVA] share price is $2.36. The Score for SAVA is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • SAVA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
27
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $245.50. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SAVA Stock Price Chart

What is Cassava Sciences's stock price today?

  • The Cassava Sciences share price today is $2.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SAVA is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $245.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.

SAVA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -4.77 Sell
Relative Strength Index (14 RSI): 22.86 Sell
Chaikin Money Flow: 1414507 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (-1.63 - 19.71) Sell
Bollinger Bands (100): (13.1 - 32.86) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.01 Sell
Relative Strength Index (14 RSI): 43.61 Sell
Chaikin Money Flow: 935904 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (240.56 - 254.54) Sell
Bollinger Bands (100): (251.01 - 281.19) Sell

SAVA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.58 Sell
20-day SMA: 4.25 Sell
50-day SMA: 17.9 Sell
200-day SMA: 21.04 Sell
8-day EMA: 2.78 Sell
20-day EMA: 6.44 Sell
50-day EMA: 14.12 Sell
200-day EMA: 20.57 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 244.71 Buy
20-day SMA: 249.56 Sell
50-day SMA: 264.07 Sell
200-day SMA: 220.46 Buy
8-day EMA: 244.75 Buy
20-day EMA: 249.26 Sell
50-day EMA: 256.57 Sell
200-day EMA: 234.24 Buy

Cassava Sciences Earnings Growth & SAVA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.64 per share, and an increase next year of $0.37 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.71 per share.

Cassava Sciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):